InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: Doktornolittle post# 95582

Saturday, 01/14/2017 10:44:23 AM

Saturday, January 14, 2017 10:44:23 AM

Post# of 705233
Why keep NWBO around if L GBM approved? If Direct proves out this GBM indication will be a drop in the bucket. Further, there are many other possible indications for L, including Prostate if the big dogs get involved as partners. I don't know if Cognate could carry all that. Maybe. But that is what you would have to visualize happening. The Direct trials all moving over to Cognate. All new trials moving to Cognate. Would the relationship with UCLA be maintained if LP became an infamous retail investor scrwr? (of course some claim that is already the case).

I don't know if all that happening has much advantage for LP over staying the course if L proves out here. The future potential for the company would become so enormous that it just wouldn't make sense to mess with it in my opinion. Though I do understand your concern... but also wonder if you (BioBoom) want to put in a temporary stop at $5.88 so you could still get in if approved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News